Kimberly-Clark Corporation $KMB Stock Holdings Trimmed by International Assets Investment Management LLC

International Assets Investment Management LLC trimmed its stake in shares of Kimberly-Clark Corporation (NASDAQ:KMB) by 54.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,847 shares of the company’s stock after selling 15,053 shares during the period. International Assets Investment Management LLC’s holdings in Kimberly-Clark were worth $1,252,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. BlackRock Inc. purchased a new stake in shares of Kimberly-Clark during the second quarter worth about $3,547,915,000. Bank of America Corp DE raised its position in shares of Kimberly-Clark by 3.3% during the 2nd quarter. Bank of America Corp DE now owns 6,881,641 shares of the company’s stock worth $755,398,000 after purchasing an additional 219,742 shares during the last quarter. Thornburg Investment Management Inc. purchased a new position in Kimberly-Clark in the 2nd quarter valued at about $632,373,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Kimberly-Clark by 8.7% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,116,768 shares of the company’s stock valued at $342,128,000 after buying an additional 249,832 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Kimberly-Clark by 0.9% in the 1st quarter. Bank of New York Mellon Corp now owns 2,237,904 shares of the company’s stock valued at $215,891,000 after buying an additional 18,989 shares in the last quarter. Institutional investors and hedge funds own 76.29% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on KMB. Deutsche Bank Aktiengesellschaft lifted their price objective on Kimberly-Clark from $106.00 to $112.00 and gave the stock a “hold” rating in a report on Wednesday, August 5th. Canaccord Genuity Group started coverage on Kimberly-Clark in a report on Friday, October 23rd. They set a “hold” rating and a $105.00 target price for the company. Seaport Research Partners upgraded Kimberly-Clark to a “buy” rating in a research report on Tuesday, August 4th. Bank of America lowered their price target on Kimberly-Clark from $122.00 to $120.00 and set a “buy” rating on the stock in a research note on Friday, September 25th. Finally, Zacks Research cut Kimberly-Clark from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 20th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Kimberly-Clark has an average rating of “Hold” and a consensus price target of $110.67.

Key Headlines Impacting Kimberly-Clark

Here are the key news stories impacting Kimberly-Clark this week:

• Positive Sentiment: The completed Kenvue acquisition expands Kimberly-Clark’s presence in health and wellness and adds brands including Tylenol to its portfolio, potentially creating new growth opportunities. The deal’s enterprise value was reported at nearly $49 billion. Kimberly Clark Completes Kenvue Acquisition
• Positive Sentiment: Kimberly-Clark’s dividend history may appeal to income-focused investors: it has paid dividends for 92 consecutive years and increased payouts for 54 years. Its dividend yield was cited at about 4.7%, with recent annual net income of $2.5 billion in 2024 and $2 billion in 2025 supporting the payout. Is Kimberly-Clark the Safest Dividend Stock You Can Buy Now?
• Positive Sentiment: Reports that ETFs bought $132.9 million of KMB shares on Oct. 30 point to notable institutional demand, though the report alone does not establish whether that buying will continue. ETFs Bought $132.9 Million of Kimberly-Clark
• Neutral Sentiment: Investors are looking ahead to the Nov. 5 earnings report for updates on quarterly performance and the company’s outlook, including how management expects to handle the Kenvue combination. Kimberly-Clark Acquires Kenvue Ahead of Earnings
• Negative Sentiment: The nearly $49 billion transaction is large, and Kimberly-Clark’s exchange offer involved up to $7 billion of new company notes plus cash for Kenvue notes. The added financing burden and execution risks could weigh on investors’ assessment of the deal’s benefits. Exchange Offers for Kenvue Notes

Kimberly-Clark Stock Performance

NASDAQ:KMB opened at $108.79 on Thursday. The company’s 50-day moving average price is $102.61 and its 200-day moving average price is $103.14. The company has a current ratio of 0.91, a quick ratio of 0.69 and a debt-to-equity ratio of 3.45. The company has a market cap of $36.18 billion, a P/E ratio of 14.02, a P/E/G ratio of 6.03 and a beta of 0.25. Kimberly-Clark Corporation has a twelve month low of $92.42 and a twelve month high of $116.82.

Kimberly-Clark (NASDAQ:KMB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.80 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.01 by ($0.21). Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. The business had revenue of $4.19 billion for the quarter, compared to analysts’ expectations of $4.22 billion. During the same period in the prior year, the company posted $1.92 EPS. The firm’s revenue was up .6% on a year-over-year basis. On average, sell-side analysts forecast that Kimberly-Clark Corporation will post 6.83 earnings per share for the current fiscal year.

About Kimberly-Clark

Kimberly-Clark Corporation (NASDAQ:KMB) is a global consumer products company that develops and markets personal care, tissue and professional hygiene products. Its portfolio includes products for babies and children, feminine care, adult care, family care and workplace hygiene.

The company’s well-known brands include Huggies diapers and wipes, Kleenex facial tissue, Cottonelle bathroom tissue, Scott toilet paper and paper towels, Kotex feminine care products, and Depend, Poise and GoodNites products.